Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster

Vaccine

Volumn 28, Issue 19, 2010, Pages 3385-3397

  Brisson, Marc ^a,b   Melkonyan, Gurgen ^b,c   Drolet, Melanie ^a,b   De Serres, Gaston ^a,b,c   Thibeault, Roseline ^a   De Wals, Philippe ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Dynamic transmission model; Vaccines; Varicella zoster virus

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHICKENPOX; CHILD; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFICACY; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VARICELLA ZOSTER VIRUS;

EID: 77950518703     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.079     Document Type: Article

References (47)

1. Schuette M.C., and Hethcote H.W. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61 Nov (6) (1999) 1031-1064
2. Weibel R.E., Kuter B.J., Neff B.J., Rothenberger C.A., Fitzgerald A.J., Connor K.A., et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 254 Nov (17) (1985) 2435-2439
3. White C.J., Kuter B.J., Hildebrand C.S., Isganitis K.L., Matthews H., Miller W.J., et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987-1989. Pediatrics 87 May (5) (1991) 604-610
4. Clements D.A., Moreira S.P., Coplan P.M., Bland C.L., and Walter E.B. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatr Infect Dis J 18 Dec (12) (1999) 1047-1050
5. Kuter B., Matthews H., Shinefield H., Black S., Dennehy P., Watson B., et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23 Feb (2) (2004) 132-137
6. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58 Jan (1965) 9-20
7. Thomas S.L., Wheeler J.G., and Hall A.J. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360 Aug (9334) (2002) 678-682
8. Brisson M., Gay N.J., Edmunds W.J., and Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20 Jun (19-20) (2002) 2500-2507
9. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125 Dec (3) (2000) 651-669
10. Brisson M., Edmunds W.J., and Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70 Suppl 1 (2003) S31-S37
11. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287 Feb (5) (2002) 606-611
12. Davis M.M., Patel M.S., and Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114 Sep (3) (2004) 786-792
13. Kwong J.C., Tanuseputro P., Zagorski B., Moineddin R., and Chan K.J. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?. Vaccine 26 Nov (47) (2008) 6006-6012
14. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., and Shefer A. Impact of varicella vaccination on health care utilization. JAMA 294 Aug (7) (2005) 797-802
15. Mullooly J.P., Maher J.E., Drew L., Schuler R., and Hu W. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine 22 Mar (11-12) (2004) 1480-1485
16. Russell M.L., Svenson L.W., Yiannakoulias N., Schopflocher D.P., Virani S.N., and Grimsrud K. The changing epidemiology of chickenpox in Alberta. Vaccine 23 Nov (46-47) (2005) 5398-5403
17. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children: Michigan, 2003. Morbidity and Mortality Weekly Report 2004; 53:389-92.
18. Tugwell B.D., Lee L.E., Gillette H., Lorber E.M., Hedberg K., and Cieslak P.R. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 113 Mar (3 Pt 1) (2004) 455-459
19. Lee B.R., Feaver S.L., Miller C.A., Hedberg C.W., and Ehresmann K.R. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis 190 Aug (3) (2004) 477-483
20. Lopez A.S., Guris D., Zimmerman L., Gladden L., Moore T., Haselow D.T., et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117 Jun (6) (2006) e1070-e1077
21. Vazquez M., LaRussa P.S., Gershon A.A., Steinberg S.P., Freudigman K., and Shapiro E.D. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 344 Mar (13) (2001) 955-960
22. Izurieta H.S., Strebel P.M., and Blake P.A. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 278 Nov (18) (1997) 1495-1499
23. Clements D.A., Armstrong C.B., Ursano A.M., Moggio M.M., Walter E.B., and Wilfert C.M. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Pediatr Infect Dis J 14 Oct (10) (1995) 874-879
24. Chaves S.S., Gargiullo P., Zhang J.X., Civen R., Guris D., Mascola L., et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356 Mar (11) (2007) 1121-1129
25. Vazquez M., LaRussa P.S., Gershon A.A., Niccolai L.M., Muehlenbein C.E., Steinberg S.P., et al. Effectiveness over time of varicella vaccine. JAMA 291 Feb (7) (2004) 851-855
26. Civen R., Chaves S.S., Jumaan A., Wu H., Mascola L., Gargiullo P., et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28 Nov (11) (2009) 954-959
27. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., and Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 133 Apr (2) (2005) 245-253
28. Jumaan A.O., Yu O., Jackson L.A., Bohlke K., Galil K., and Seward J.F. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 191 Jun (12) (2005) 2002-2007
29. Yih W.K., Brooks D.R., Lett S.M., Jumaan A.O., Zhang Z., Clements K.M., et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 5 (2005) 68
30. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 Oct (2) (2001) 305-314
31. Advisory Committee on Immunization Practices. Record of the Proceedings 2006 [cited 2009 November 4]; Available from: http://www.cdc.gov/vaccines/recs/acip/downloads/min-jun06.pdf.
32. Statistics Canada. 2002 [cited 2009 November 4]; Available from: http://www.statcan.ca/english/freepub/84F0211XIE/2002/tables.htm.
33. Gidding H.F., Brisson M., Macintyre C.R., and Burgess M.A. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health 29 Dec (6) (2005) 544-551
34. Anderson R.M., and May R.M. Infectious diseases of humans: dynamics and control (1991), Oxford University Press, Oxford
35. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5 Mar (3) (2008) e74
36. Nardone A., de Ory F., Carton M., Cohen D., van Damme P., Davidkin I., et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25 Nov (45) (2007) 7866-7872
37. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 Jun (22) (2005) 2271-2284
38. Brisson M., Pellissier J.M., Camden S., Quach C., and De Wals P. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccin 4 Jun (3) (2008 Jan 25)
39. Pellissier J.M., Brisson M., and Levin M.J. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine 25 Nov (49) (2007) 8326-8337
40. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 18 Jun (25) (2000) 2775-2778
41. Gao Z., Gidding H.F., Wood J.G., and Macintyre C.R. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect Apr (138) (2010) 457-468
42. Zagheni E., Billari F.C., Manfredi P., Melegaro A., Mossong J., and Edmunds W.J. Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol 168 Nov (9) (2008) 1082-1090
43. Hens N., Aerts M., Faes C., Shkedy Z., Lejeune O., VAND P., et al. Seventy-five years of estimating the force of infection from current status data. Epidemiol Infect Sep (2009) 1-11
44. Ogunjimi B., Hens N., Goeyvaerts N., Aerts M., Van Damme P., and Beutels P. Using empirical social contact data to model person to person infectious disease transmission: An illustration for varicella. Math Biosci 218 Apr (2) (2009) 80-87
45. Effelterre T.V., Shkedy Z., Aerts M., Molenberghs G., Damme P.V., and Beutels P. Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus. Epidemiol Infect 137 Jan (1) (2009) 48-57
46. Guris D., Jumaan A.O., Mascola L., Watson B.M., Zhang J.X., Chaves S.S., et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis 197 Mar (Suppl 2) (2008) S71-S75
47. Boulianne N., Duval B., De Serres G., Deceuninck G., Masse R., and Couillard M. Most ten-year-old children with negative or unknown histories of chickenpox are immune. Pediatr Infect Dis J 20 Nov (11) (2001) 1087-1088